Publication new article
Employees from RTM and Radboudumc have published a new article: 'Production of novel diagnostic radionuclides in small medical cyclotrons'.
Read the abstract below and click here to read the full article.
The global network of cyclotrons has expanded rapidly over the last decade. The bulk of its industrial potential is composed of small medical cyclotrons with a proton energy below 20 MeV for radionuclides production. This review focuses on the recent
developments of novel medical radionuclides produced by cyclotrons in the energy range of 3 MeV to 20 MeV. The production of the following medical radionuclides will be described based on available literature sources: Tc-99 m, I-123, I-124, Zr-89, Cu-64,
Ga-67, Ga-68, In-111, Y-86 and Sc-44. Remarkable developments in the production process have been observed in only some cases. More research is needed to make novel radionuclide cyclotron production available for the medical industry.
On May 21st, the first patient dosis of QuiremSpheres was processed at RTM and then shipped to the s...
Radboud Translational Medicine will perform the dispensing of below product. The production and dis...
Fluorodopa (18F) is now available for clinical studies and - with doctor's certificate - for routine...